Azetidine derivatives as CCR-3 receptor antagonists

Details for Australian Patent Application No. 2005270308 (hide)

Owner Novartis AG

Inventors Legrand, Darren Mark

Agent Davies Collison Cave

Pub. Number AU-B-2005270308

PCT Pub. Number WO2006/015854

Priority 0417801.8 10.08.04 GB

Filing date 9 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 22 October 2009

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015854 Priority application(s): WO2006/015854

22 October 2009 Application Accepted

  Published as AU-B-2005270308

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270313-Trifluoromethyl substituted benzamides as kinase inhibitors

2005270306-Organic compounds